BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 19700158)

  • 21. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
    Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
    Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
    Blomster H; Puustjärvi T; Kontkanen M; Valtonen P; Teräsvirta M; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADMA, subclinical changes and atrial fibrillation in the general population.
    Ramuschkat M; Appelbaum S; Atzler D; Zeller T; Bauer C; Ojeda FM; Sinning CR; Hoffmann B; Lackner KJ; Böger RH; Wild PS; Münzel T; Blankenberg S; Schwedhelm E; Schnabel RB;
    Int J Cardiol; 2016 Jan; 203():640-6. PubMed ID: 26580348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage.
    Appel D; Seeberger M; Schwedhelm E; Czorlich P; Goetz AE; Böger RH; Hannemann J
    Neurocrit Care; 2018 Aug; 29(1):84-93. PubMed ID: 29560598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
    Oliva-Damaso E; Oliva-Damaso N; Rodriguez-Esparragon F; Payan J; Baamonde-Laborda E; Gonzalez-Cabrera F; Santana-Estupiñan R; Rodriguez-Perez JC
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
    Pilz S; Putz-Bankuti C; Meinitzer A; März W; Kienreich K; Stojakovic T; Pieber TR; Stauber RE
    Amino Acids; 2015 Sep; 47(9):1817-26. PubMed ID: 25952253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Dimethylarginine Levels and Carotid Intima-Media Thickness are related to Atrial Fibrillation in Patients with Embolic Stroke.
    Grosse GM; Biber S; Sieweke JT; Martens-Lobenhoffer J; Gabriel MM; Putzer AS; Hasse I; van Gemmeren T; Schuppner R; Worthmann H; Lichtinghagen R; Bode-Böger SM; Bavendiek U; Weissenborn K
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane.
    Mommersteeg PM; Schoemaker RG; Eisel UL; Garrelds IM; Schalkwijk CG; Kop WJ
    Psychosom Med; 2015 Apr; 77(3):292-302. PubMed ID: 25790241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
    Jud P; Hafner F; Verheyen N; Gary T; Meinitzer A; Brodmann M; Seinost G; Hackl G
    Heart Vessels; 2018 Dec; 33(12):1453-1462. PubMed ID: 29946762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase].
    Masuda H; Azuma H
    Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):29-35. PubMed ID: 11862754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arginine Derivatives in Cerebrovascular Diseases: Mechanisms and Clinical Implications.
    Grosse GM; Schwedhelm E; Worthmann H; Choe CU
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
    Paroni R; Barassi A; Ciociola F; Dozio E; Finati E; Fermo I; Ghilardi F; Colpi GM; Corsi MM; Melzi d'Eril GV
    Int J Androl; 2012 Oct; 35(5):660-7. PubMed ID: 22519580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
    Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADMA and arginine derivatives in relation to non-invasive vascular function in the general population.
    Baum C; Johannsen SS; Zeller T; Atzler D; Ojeda FM; Wild PS; Sinning CR; Lackner KJ; Gori T; Schwedhelm E; Böger RH; Blankenberg S; Münzel T; Schnabel RB;
    Atherosclerosis; 2016 Jan; 244():149-56. PubMed ID: 26638011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.